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Abstract
Background: Regulatory elements that control expression of specific genes during development have been shown
in many cases to contain functionally-conserved modules that can be transferred between species and direct gene
expression in a comparable developmental pattern. An example of such a module has been identified at the rat
myosin light chain (MLC) 1/3 locus, which has been well characterised in transgenic mouse studies. This locus
contains two promoters encoding two alternatively spliced isoforms of alkali myosin light chain. These promoters
are differentially regulated during development through the activity of two enhancer elements. The MLC3
promoter alone has been shown to confer expression of a reporter gene in skeletal and cardiac muscle in
transgenic mice and the addition of the downstream MLC enhancer increased expression levels in skeletal muscle.
We asked whether this regulatory module, sufficient for striated muscle gene expression in the mouse, would drive
expression in similar domains in the chicken.
Results: We have observed that a conserved downstream MLC enhancer is present in the chicken MLC locus. We
found that the rat MLC1/3 regulatory elements were transcriptionally active in chick skeletal muscle primary
cultures. We observed that a single copy lentiviral insert containing this regulatory cassette was able to drive
expression of a lacZ reporter gene in the fast-fibres of skeletal muscle in chicken in three independent transgenic
chicken lines in a pattern similar to the endogenous MLC locus. Reporter gene expression in cardiac muscle tissues
was not observed for any of these lines.
Conclusions: From these results we conclude that skeletal expression from this regulatory module is conserved in
a genomic context between rodents and chickens. This transgenic module will be useful in future investigations of
muscle development in avian species.
Background
The development of an organism entails the precise
expression of lineage and tissue-specific gene products
in a temporally-regulated manner during embryogenesis.
The information for a cell to respond to external signals
by differentiating down a particular developmental path-
way is ‘hardwired’ into the regulatory regions surround-
ing these developmentally regulated genes [reviewed in
[1]]. These conserved regulatory regions or modules
drive spatial gene expression patterns in the forming tis-
sues of the developing organism. Changes in the cis-reg-
ulatory elements of regulatory modules are hypothesized
to be the predominant mechanism behind evolutionary
changes in pattern formation [2].
Many expression modules have been shown to be
functionally conserved in vertebrate species. For exam-
ple, regulatory regions from several hox genes from fish
and chicken are capable of driving some aspects of the
spatial expression patterns of the paralogous murine
gene in transgenic mice [3-6]. Examples of conserved
regulatory modules have been shown for the processes
of neurogenesis [7-9], limb morphogenesis [10] and hae-
matopoiesis [11,12], amongst many other examples.
We, and others, have previously shown that lentiviral
vectors can be used to generate transgenic chickens and
that cis-regulatory regions incorporated into these vec-
tors will drive ubiquitous or tissue-specific expression in
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possibility of utilising rodent regulatory elements to
drive transgene expression in skeletal muscle of chick-
ens. To achieve this we investigated the transcriptional
activity of the rat MLC regulatory domains in transgenic
chickens. This locus encodes two alkali myosin light
chains expressed from two promoters that are differen-
tially regulated during development. The MLC1 isoform
is expressed at embryonic stages of development and in
the fast fibres of skeletal muscles of the adult. The
MLC3 isoform is expressed at fetal stages and in the
atria of the mouse heart [17,18]. The construct we used
consists of the rat MLC3 promoter, which is transcrip-
tionally active in all striated muscle in mouse transgenic
models [18,19], and a downstream rat MLC enhancer
which augments skeletal muscle expression and confers
expression at embryonic stages of development [20,21].
We show that a putative MLC enhancer is present in
the chicken MLC locus. Using the rat MLC regulatory
elements, we show that these elements support trans-
gene expression in skeletal muscle of chickens. Cardiac
transgene expression was not detected. These results
indicate a functional conservation of the MLC regulatory
elements exist between rodents and chickens in the ske-
letal muscle lineage. This demonstration is significant
not only for the use of the chicken as a model organism
for studies in developmental biology but also because
poultry are an economically important food source.
Results and Discussion
The mammalian MLC locus consists of two widely sepa-
rated promoters driving expression of two protein iso-
forms of the alkali MLC and a downstream enhancer
[20,22-24]. The exon structure of the chicken, rat,
mouse, and human myosin light chain 1/3 locus is
highly conserved [22-26]. (Fig. 1top). The rat and mouse
MLC enhancer and the MLC1 promoters were pre-
viously shown to drive robust expression in fast skeletal
muscle of transgenic mice [20,21]. Cardiac expression
was shown to be dependant on the MLC3 promoter
[18,19].
Examination of the chicken locus at an analogous
position for the MLC enhancer enabled us to identify a
region of homology shared with human, rat, mouse, and
opossum (Fig. 1bottom). A closer examination of this
region revealed a putative enhancer module containing
regulatory elements that closely resemble the core myo-
sin light chain enhancer as defined in mouse, rat and
human [19,27,28]. This core enhancer contains three
canonical E boxes (CANNTG) that bind to the myo-
genic factors, myf-5, MRF4, myoD, and myogenin and
an A/T rich region containing a sequence matching the
consensus binding site of MEF2 [27]. All four regulatory
motifs are present in this DNA sequence as indicated in
Fig. 1. These data suggest that the structure of the
MLC1/3 locus is highly conserved between mammals
and chicken.
Generation of a muscle-specific reporter cassette
To define a regulatory module that is sufficient for gene
expression in the striated muscle of transgenic chickens,
we used the regulatory regions from the rat MLC1/3
locus to drive expression of a lacZ reporter gene. These
elements were both introduced upstream of the lacZ
reporter gene in a minimal EIAV replication-defective
lentiviral vector to create the construct pONY-MLZ
(Fig. 1C). To test the transcriptional activity of the lenti-
viral construct in chicken cells, transient transfections of
the construct were carried out into primary cultures of
embryonic chicken cardiac and skeletal muscle cells and
the transfected cells were stained for b-galactosidase
activity (Fig. 2). An upstream CMVenhancer/promoter
regulatory region used for packaging the lentiviral con-
struct was first removed from this plasmid to avoid pos-
sible transactivation of the downstream MLC3 promoter
(see Methods). A GFP reporter construct was co-trans-
fected to visualise transfection efficiency into these cells
(Fig. 2A, 2B). Transfections into skeletal muscle primary
cultures demonstrated that long myotubular cells
stained positive for b-galactosidase whilst surrounding
fibroblasts did not (Fig. 2B’). In transfections into car-
diac muscle primary cultures, no expression of b-galac-
tosidase was detected (Fig. 2A’). These results indicate
that the MLC regulatory module is transcriptionally
active in skeletal muscle cells but is not active in cardiac
muscle. We went on to test this module in vivo using
transgenesis.
Generation of transgenic chickens carrying the
MLC-lacZ transgene
To generate transgenic chickens containing a MLC
transgene, a concentrated preparation of pONY-MLZ
replication-defective lentivirus was produced. The virus
was injected into the sub-germinal cavity of fertilised
eggs at the new-laid egg stage. Injected eggs were incu-
bated until hatching using the surrogate shell culture
system as described [13]. A total of 12 chickens were
hatched and all were identified as transgenic for the
EIAV vector by semi-quantitative PCR of DNA from
blood samples. One cockerel, estimated to have an inci-
dence of 10% transgene integration in the germline by
PCR analysis of semen DNA, was bred with stock hens
and G1 transgenic offspring identified. Seven G1 off-
spring were produced and genomic DNA from these
birds analyzed by restriction enzyme digestion and
Southern blot analysis to determine the number of vec-
tor insertions in each bird and the number of different
insertion events represented in the G1 generation.
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Page 2 of 10Figure 1 The rat MLC1/3 locus and lentiviral construct. Top: The rat MLC locus consists of two separate promoter elements which generate
two alternatively spliced transcripts. A downstream enhancer augments expression from both promoters in skeletal muscle. Stippled exons are
specific for MLC3. The internal MLC3 promoter and the downstream enhancer were cloned upstream of a lacZ reporter construct in an EIAV
replication defective lentiviral vector to generate pONY-MLZ. Restriction sites for HindIII (red arrows) and Sph1 (black arrows) are indicated.
Bottom: Sequence comparison of homologous downstream regions of the MLC1/3 locus of eutherans and chickens. Grey boxes highlight core
enhancer elements identified in human, mouse, and rat. The internal basepairs of the E box of Site A are changed to the sequence of site B in
the chicken. Site C is in reverse orientation in the chicken to that in mammals.
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Page 3 of 10Genomic DNA digested with HindIII and Sph1g e n e r -
ated junction fragments that revealed that all seven
birds contained single vector insertions and four inde-
pendent insertions were present in the G1 birds (Fig. 3).
Four G1 birds, each carrying a different transgene inte-
grant, were bred to generate G2 birds which were ana-
lysed in the subsequent experiments.
Transgene expression is limited to avian skeletal muscle
To determine the transcriptional profile of the MLC
expression module in transgenic chickens, selected tis-
sues from chickens carrying each of the four indepen-
dent vector insertions were assayed for b-galactosidase
protein by ELISA (Fig. 4, top). b-galactosidase protein
was detected in breast and leg muscle of three trans-
genic lines (lines 2, 18, 75). The skeletal muscle expres-
sion levels were relatively robust. For example in line
75, 0.25% of the total protein in skeletal muscle was b-
galactosidase. Non-muscle tissues did not contain b-
galactosidase. No b-galactosidase was detected in tissue
samples from the fourth transgenic line (line 76). It is
possible that the integrated vector for this line has
acquired a mutation that inactivated the transgene or
that it has integrated into a transcriptionally silent site.
Unexpectedly, no b-galactosidase was detected in
heart atria or ventricles of birds from any of the three
expressing lines. In transgenic mice, the MLC3 promo-
ter alone drove b-galactosidase expression in cardiac
muscle of transgenic mice (3 of 3 mouse lines) [18].
Addition of the MLC enhancer to the transgene con-
struct inhibited expression in cardiac tissues of two out
of three transgenic mouse lines. A similar effect was
also reported by Zammit et al., [21]. The lack of expres-
sion in cardiac tissue from the transgenic chickens
Figure 2 MLC3 regulatory elements are transcriptionally active in chicken skeletal muscle but not cardiac muscle primary cultures.
Cardiac (A, A’) and skeletal (B, B’) muscle chick primary cultures were co-transfected with the MLC3 lentiviral construct and a CAG-GFP reporter
construct. Three independent experiments were carried out and a representative field is shown. A, B: GFP fluorescence A’B’: X-gal staining of
primary cultures. Large myotubes are stained in B’.
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Page 4 of 10mimicked the result obtained by transfection experi-
ments into chicken cardiomyocytes and was also similar
to the expression patterns observed in transgenic mice
for constructs containing the MLC enhancer.
T i s s u e sf r o mt h et r a n s g e n i ca d u l tb i r d sw e r es t a i n e d
for b-galactosidase activity to observe the spatial expres-
sion pattern in skeletal muscle. Non-muscle tissues and
cardiac muscle did not stain for b-galactosidase (Fig. 4,
bottom). Pectoral muscle of the breast was entirely
stained for b-galactosidase. Immunofluorescence of
chicken pectoral muscle with an antibody to chicken
myosin light chain 1 and 3 revealed extensive expression
throughout this tissue (Fig. 4C). In contrast to the pec-
toral musculature, staining of leg muscle displayed a
cobbled expression pattern. Chicken pectoral muscle
contains predominantly fast fibre muscle (white muscle)
whereas leg musculature contains both fast and slow
muscle fibres (red muscle) [29,30]. This result suggests
that the transgene is expressed extensively in the fast
fibre tissue of the breast flight muscle and is restricted
in expression in leg muscle which contains slow as well
as fast muscle fibres.
Tissue from the leg muscle was stained for b-galacto-
sidase and an adjacent section immunostained with fast
and slow fibre-specific antibodies [31], to demonstrate
that the transgene expression is limited to fast fibres.
T h er e s u l t ss h o w ni nF i g .5 Aa n d5 Bd e m o n s t r a t et h a t
the fibres that stained for b-galactosidase activity were
also labelled with the fast fibre marker, F59. Conversely,
fibres negative for b-galactosidase activity were
immuno-positive for the slow fibre marker, S58. This
finding is in accordance with results obtained in mouse
models, which demonstrated that the MLC1/3 regula-
tory module conferred expression to fast muscle fibres
[18,19,32].
To demonstrate that the transgene expression follows
that of the endogenous MLC1/3 locus, a tissue section
was stained for b-galactosidase and an adjacent section
immunostained with an antibody to MLC1 and 3 iso-
forms (F310) (Fig. 5C, 5D) [33]. Muscle fibres that are
negative for b-galactosidase activity are immuno-nega-
tive for MLC1 and 3 indicating that the rat regulatory
elements are expressed in a similar fibre type as the
endogenous gene.
The MLC module drives early embryonic expression
We next examined the temporal expression pattern of
the MLC construct at selected embryonic stages and
compared these expression patterns with those of the
endogenous locus, to determine if the transgenic con-
struct is accurately developmentally regulated. Staining
of chicken embryos for b-galactosidase activity revealed
that the MLC transgene was expressed in the forming
myotome of day 3 (HH stage 19) chicken embryos (Fig.
6A-6C). In situ hybridisation with a riboprobe specific
for MLC1 and 3 mRNA also revealed that the endogen-
ous chicken locus is transcribed in the chicken myotome
at this stage (Fig. 6D). Abundant staining of the cardiac
tube was also apparent. An analysis of later stages
revealed extensive staining of b-galactosidase activity
through the forming muscle masses of day 10 (mid-
incubation) transgenic chicken embryos (Fig. 6E, 6F).
These analyses show that the MLC regulatory module is
sufficient to drive embryonic expression in skeletal mus-
cles of chicken but not in cardiac tissue. Transgenic
constructs containing these regulatory elements had pre-
viously been shown to be expressed in the myotome of
developing transgenic mouse embryos [18,19,21]. Thus,
our results indicate a conservation of temporal expres-
sion patterns between rodents and chicken.
Conclusion
These experiments are a further demonstration that the
chicken can be used as an alternative model for trans-
genic analysis of gene regulation and of the use of lenti-
virus in avian transgenesis. These results indicate that
the MLC regulatory module is functionally conserved
for fast muscle fibre expression in mammals and birds
and is developmentally regulated. Regulatory regions in
the MLC enhancer are also conserved between mam-
mals and chicken (Fig. 1). In contrast, sequences in the
MLC3 promoter are divergent when compared to the
Figure 3 Southern blot analysis of transgenic G1 chickens.
Genomic DNA from birds containing the MLZ proviral sequences
were analysed for integration events by digestion with HindIII (left)
or Sph1 (right) to generate junction fragments. The number of G1
birds generating identical junction fragments is indicated.
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Page 5 of 10Figure 4 Transgene expression is limited to skeletal muscle. Top: Protein samples from various tissues were analysed by ELISA for the
presence of b-galactosidase. Each data point is the average of two independent assays on tissues from one transgenic bird for each line. Birds
were a minimum of four months of age when assayed. Line 76 is not visible on the graph due to the low expression levels of this line. Bottom:
Sections from various tissues of the same birds were stained for b-galactosidase activity. A) Transgenic breast muscle. B) Transgenic leg muscle.
C) Immunofluorescence of the endogenous MLC1 and 3 protein D) Control breast muscle. E) Transgenic atrium. F) Transgenic ventricle. Staining
in skin appears to be in striated muscles associated with feather tracts. Scale bars, 0.5 mm.
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Page 6 of 10MLC1 promoter [18,25]. The GATA regulatory element
of the rat MLC3 promoter, essential for cardiac expres-
sion in the rat, is not conserved in the chicken MLC3
promoter, yet there is expression from the endogenous
MLC1/3 locus in the embryonic chicken heart (Fig. 6D),
suggesting that regulatory modules for avian cardiac
expression are divergent from those in mammals.
T h ec o n s t r u c td e s c r i b e dh e r ew i l lb eu s e f u la sa n
expression module to drive skeletal muscle expression
in avian species. This will have applications for the
expression of proteins or RNAs in avian muscle tissue
for studies of muscle differentiation and function. For
example, the expression of microRNAs targeting genes
involved in skeletal muscle myopathy in broiler chickens
could be specifically targeted to skeletal muscle using
this regulatory module [34]. Additionally, similarly con-
structed transgenes will permit the analysis of candidate
genes, identified by QTL mapping and expression ana-
lyses, implicated in control of muscle mass in chicken
lines selected for increased muscle mass [35,36]. Inher-
ent difficulties still remain in the generation of
transgenic chickens including the long period to sexual
maturity (16 weeks) and the difficulties in generating
high titre lentivirus for large and complex transgenes.
Methods
Lentivirus construction and packaging
The 628 bp MLC3 promoter was isolated from
p628Luc920 [18] using HindIII and subcloned into the
HindIII site of the minimal EIAV lentiviral vector
pONY8.45NCmcs [15]. A lacZ reporter gene was iso-
lated from pONY 8.45NCZ using Sph1a n dXho1a n d
subcloned into the Xho1a n dNru1 sites of the above
plasmid to generate pONY8.45NCMLC3-Z. A residual
CMV promoter was deleted from this vector by diges-
tion with EcoR1 and SacII and re-ligation of the plas-
mid. Finally, a 920 bp MLC enhancer fragment was
isolated from p628Luc920 [18] using BamH1 and sub-
cloned into the Not1 site upstream of the introduced
promoter fragment to generate pONY8.45N-E-MLC3-Z
(pONY-MLZ). The original direction of the enhancer
was reversed in this construct. Packaged virus stocks
Figure 5 Transgene expression is restricted to fast skeletal muscle fibres and is expressed in a similar fibre type as the endogenous
locus. A) A section from an interior leg muscle of a transgenic chicken was stained for b-galactosidase activity. The animal was at least four
months old when assayed. B) A serial section to the one above was immuno-stained for fast (red) and slow (green) muscle isoforms. Fibres that
are negative for b-galactosidase are labelled with an antibody to slow muscle. C) A section from an interior leg muscle of a second line of
transgenic chicken was stained for b-galactosidase activity. D) A serial section to the one above was immuno-stained for MLC1 and 3 muscle
isoforms (green). Fibres that are negative for b-galactosidase do not express MLC1 and 3. White arrows indicate corresponding myofibres. Scale
bars, 0.1 mm.
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Page 7 of 10were generated by FuGENE6 (Roche, Lewes, U.K.) trans-
fection of HEK 293T cells plated on 10 cm dishes with 2
μg of vector plasmid, 2 μgo fg a g / p o lp l a s m i d
(pONY3.1) and 1 μg of VSV-G plasmid (pRV67) [37].
36-48 hours after transfection supernatants were filtered
(0.22 μm) and stored at -80°C. Concentrated viral pre-
parations were made by initial low speed centrifugation
at 6,000 × g for 16 hours at 4°C followed by ultracentri-
fugation at 50,500 × g for 90 minutes at 4°C. The virus
was resuspended in formulation buffer (20 mM Tris,
100 mM NaCl, 10 mg/ml sucrose,10 mg/ml mannitol,
pH 7.4) for 2-4 hours, aliquoted and stored at -80°C.
Viral titre was estimated at 4.5 × 10
7 T.U./μl.
Production and analysis of transgenic birds
Founder transgenic birds were generated by injection of
viral particles into fertilised eggs at the new-laid egg
stage, followed by culture of the embryos to hatch as
described [13,38]. The hatched chicks were raised to;
sexual maturity and DNA extracted from semen from
Figure 6 Transgene expression in the forming chicken embryo. Transgenic and control embryos were stained for of b-galactosidase activity.
A) Transgenic and (B) control embryos at day 3 of development. C) Higher magnification of the embryo in (A) to show staining in the forming
myotome. D) Transcripts from the endogenous locus at day 3 are revealed by in situ hybridisation for both MLC1 and 3. E) Transgenic and (F)
control embryos at day 10 of development. Arrow, myotome.
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Page 8 of 10adult males was screened by PCR (13) to; identify cock-
erels that carried vector sequences in the germ line.
O n ec o c k e r e li d e n t i f i e db yt h i sm e t h o dw a sc r o s s e dt o ;
stock hens and their offspring screened by PCR to; iden-
tify G1 hemizygous transgenic birds. All experiments,
animal breeding, and care procedures were carried out
under license from the U.K. Home Office.
The vector insertions in individual G1 birds were ana-
lyzed by Southern transfer. Genomic DNA (10 μg),
extracted from whole blood, was digested with HindIII
or Sph1 restriction endonucleases, resolved on a 0.7%
agarose gel, and transferred to Hybond-N membrane
(Amersham Biosciences, U.K.). These blots were ana-
l y z e db yu s i n gap r o b eo ft h elacZ coding sequence,
labelled with [
32P]dCTP using a RediPrime II kit (Amer-
sham Biosciences). Hybridization was in 500 mM
sodium phosphate (pH 7.2)/7% SDS at 65°C and signal
was detected by autoradiography.
Transfection of chicken primary cultures
The lentiviral plasmids described above were digested
with Bgl II and Xba I and re-ligated to remove a 1.8 kb
CMV enhancer/promoter fragment used for transcribing
the lentiviral constructs during packaging and which
could potentially transactivate the downstream MLC3
promoter (pONY-MLZ-del CMV constructs).
Skeletal or cardiac tissue was isolated from day 9
chicken embryos, macerated and dissociated in trypsin
for 3 × 5 minutes with vigorous pipetting. The solution
was spun at 1000 × g, 5 minutes, and re-suspended in
plating media (10%FBS, 1% chick serum in DMEM, 1×
NEAA). On day two of culture, cells were transfected
using Fugene HD (Roche) with 5 ug of pONY-MLZ (del
CMV) constructs and 1 ug of CAG-GFP in 35 mm tis-
sue culture plates (Primaria, BD Biosciences). Culture
media for skeletal muscle cultures was changed to dif-
ferentiation media (2% chick serum in DMEM, 1×
NEAA) after 24 hours. All plates were incubated for two
additional days, photographed for GFP fluorescence, and
stained for b-galactosidase activity as described below.
Analysis of b-galactosidase activity and
processing of tissues
Selected tissues were snap-frozen and total protein
extracted by homogenization in PBS containing protease
inhibitors (complete mini, Roche). Protein concentration
was determined by Bradford assay. ELISA was per-
formed using b-gal Elisa kit (Roche). Elisa assays were
carried out on two G1 birds for each integration event.
The data shown in Fig. 4 are for one transgenic animal
for each integration event.
Adult tissues were isolated, fixed for 30 min in 4%
paraformaldehyde, 0.25% gluteraldehyde in phosphate
buffered saline (PBS) and tissues cryo-embedded and
sectioned at 14 μm. b-galactosidase activity was detected
by incubating at 37°C in 5 mM potassium ferricyanide,
5 mM potassium ferrocyanide, 2 mM MgCl2, 0.5 mg/ml
X-gal for 90 minutes, counterstained with eosin and
mounted. Fast (F59) and slow (S58) fibre-type antibodies
and an antibody against MLC1 and 3 isoforms (F310),
developed by F.E. Stockdale, were obtained from the
Developmental Studies Hybridoma Bank, University of
Iowa, and used at 1:10 dilutions. The secondary antibo-
dies used were TRITC conjugated goat anti-mouse IgG
and FITC conjugated goat anti-mouse IgA (Sigma), and
Alexa Fluoro 488 conjugated goat anti-mouse IgG
respectively. Slides were counterstained with Hoechst,
and mounted with Vectashield mounting media (Vec-
tor). Whole mount in situ hybridizations were carried
out as described [39]. The riboprobe to MLC1 and 3
transcripts was described in [18].
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